logo
Select company
Select metric
-51.56%EBITDA Margin
VS
Market
15
Sector
44
Industry
41
History
100
$ 0.9Close
$ 0.43 - $ 1.22 52-Week Range
Ticker Information

Ticker

NMTC

Company Name

NEUROONE MEDICAL TECHNOLOGIES CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

NEUROONE MEDICAL TECHNOLOGIES CORP - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NMTC - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -4.97M-51.56%$ 9.63M
3/31/2025$ -6.24M-71.19%$ 8.76M
12/31/2024$ -6.82M-77.97%$ 8.75M
9/30/2024$ -11.96M-346.3%$ 3.45M
6/30/2024$ -11.74M-299.36%$ 3.92M
3/31/2024$ -12.45M-334.1%$ 3.73M
12/31/2023$ -13.14M-466.62%$ 2.82M
9/30/2023$ -11.55M-338.96%$ 3.41M
6/30/2023$ -9.82M-209.94%$ 4.68M
3/31/2023$ -9.14M-223.97%$ 4.08M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEUROONE MEDICAL TECHNOLOGIES CORP's latest trailing twelve months (TTM) EBITDA % stands at -313.77%.
  • Over the past 5 years, NEUROONE MEDICAL TECHNOLOGIES CORP's average EBITDA % has been -1345.77%.
  • The median EBITDA % for NEUROONE MEDICAL TECHNOLOGIES CORP during this period was -336.53%
  • NEUROONE MEDICAL TECHNOLOGIES CORP reached its highest EBITDA % over the past 5 years at -51.56%.
  • The lowest EBITDA % recorded by NEUROONE MEDICAL TECHNOLOGIES CORP in the same timeframe -6821.66%

NEUROONE MEDICAL TECHNOLOGIES CORP's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
VVOS : VIVOS THERAPEUTICS INC -94.12%MLSS : MILESTONE SCIENTIFIC INC -74.98%NUWE : NUWELLIS INC -46.12%MODD : MODULAR MEDICAL INC -VERU : VERU INC -479.21%HIND : VYOME HOLDINGS INC -68.69%XAIR : BEYOND AIR INC -749.56%IVF : INVO FERTILITY INC -393.7%CUE : CUE BIOPHARMA INC -435.19%BCAB : BIOATLA INC -534.19%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for NEUROONE MEDICAL TECHNOLOGIES CORP is calculated as follows: EBITDA [ $ -6.05M ] / Revenues [ $ 1.93M ]
(=) EBITDA % [ -313.77% ]

NMTC - EBITDA Margin, Last 5 years

-6821.66%

Minimum

Jun 30, 2022

-51.56%

Maximum

Jun 30, 2025

-1345.77%

Average

-336.53%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%